Work

Synthesis of a Selective Orexin 1 Receptor Antagonist: First Scale-Up Campaign Following In-Licensing

Year: 2026
Type: article
Abstract: Herein, we report the synthesis of 29.2 kg of the selective orexin 1 receptor antagonist C4X3256 monohydrate via a convergent 10-stage synthetic route. (S)-2-(Methylamino)-1-[5-(trifluoromethyl)-2-pyrazinylamino]propane was synthesized in 5 stages from l-alaninamide·HCl and isolated as the crystalline HCl salt. 6-Methyl-3-(2H-1,2,3-triazol-2-yl)pyridine-2-carboxylic acid was synthesized in 4 stages from 5-bromo-2-methylpyridine and isolated as the hemidiisopropylethylamine salt. The two advanced intermediates were combined in the final stage using T3P as a coupling reagent.
Language: English
Field: Chemistry
Open Access status: hybrid
Estimated APC paid: $4,500
OpenAlex ID: W7235868950
FWCI: 5.036
Cites: 14
Cited by: 4
Related to: 10